Clinical trial: the efficacy and safety of oral PF‐03491390, a pancaspase inhibitor – a randomized placebo‐controlled study in patients with chronic hepatitis C von SHIFFMAN, M. L., POCKROS, P., MCHUTCHISON, J. G., SCHIFF, E. R., MORRIS, M., BURGESS, G.

Volltext

Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C von McHutchison, John G, Gordon, Stuart C, Schiff, Eugene R, Shiffman, Mitchell L, Lee, William M, Rustgi, Vinod K, Goodman, Zachary D, Ling, Mei-Hsiu, Cort, Susannah, Albrecht, Janice K

Volltext

Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis C von Davis, Gary L, Esteban-Mur, Rafael, Rustgi, Vinod, Hoefs, John, Gordon, Stuart C, Trepo, Christian, Shiffman, Mitchell L, Zeuzem, Stefan, Craxi, Antonio, Ling, Mei-Hsiu, Albrecht, Janice

Volltext

A randomized, controlled trial of maintenance interferon therapy for patients with chronic hepatitis C virus and persistent viremia von Shiffman, Mitchell L., Hofmann, Charlotte M., Contos, Melissa J., Luketic, Velimir A., Sanyal, Arun J., Sterling, Richard K., Ferreira-Gonzalez, Andrea, Mills, A.Scott, Garret, Carlton

Volltext

Histological benefits of virological response to peginterferon alfa‐2a monotherapy in patients with hepatitis C and advanced fibrosis or compensated cirrhosis von EVERSON, G. T., BALART, L., LEE, S. S., REINDOLLAR, R. W., SHIFFMAN, M. L., MINUK, G. Y., POCKROS, P. J., GOVINDARAJAN, S., LENTZ, E., HEATHCOTE, E. J.

Volltext

The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts von Sanyal, AJ, Freedman, AM, Luketic, VA, Purdum, PP, Shiffman, ML, DeMeo, J, Cole, PE, Tisnado, J

Volltext

Right lobe living donor liver transplantation von MARCOS, A, FISHER, R. A, HAM, J. M, SHIFFMAN, M. L, SANYAL, A. J, LUKETIC, V. A. C, STERLING, R. K, POSNER, M. P

Volltext

Selection and outcome of living donors for adult to adult right lobe transplantation von MARCOS, A, FISHER, R. A, HAM, J. M, OLZINSKI, A. T, SHIFFMAN, M. L, SANYAL, A. J, LUKETIC, V. A. C, STERLING, R. K, OLBRISCH, M. E, POSNER, M. P

Volltext

Liver regeneration and function in donor and recipient after right lobe adult to adult living donor liver transplantation von MARCOS, A, FISHER, R. A, HAM, J. M, SHIFFMAN, M. L, SANYAL, A. J, LUKETIC, V. A. C, STERLING, R. K, FULCHER, A. S, POSNER, M. P

Volltext

Liver and Intestine Transplantation in the United States, 1995–2004 von Shiffman, M. L., Saab, S., Feng, S., Abecassis, M. I., Tzakis, A. G., Goodrich, N. P., Schaubel, D. E.

Volltext

Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection von Fried, Michael W, Shiffman, Mitchell L, Reddy, K. Rajender, Smith, Coleman, Marinos, George, Gonçales, Fernando L, Häussinger, Dieter, Diago, Moises, Carosi, Giampiero, Dhumeaux, Daniel, Craxi, Antonio, Lin, Amy, Hoffman, Joseph, Yu, Jian

Volltext

Quantitative tests of liver function measure hepatic improvement after sustained virological response: results from the HALT‐C trial von EVERSON, G. T., SHIFFMAN, M. L., HOEFS, J. C., MORGAN, T. R., STERLING, R. K., WAGNER, D. A., DESANTO, J. L., CURTO, T. M., WRIGHT, E. C.

Volltext

Review article: management of patients with chronic hepatitis C virus infection and ‘normal’ alanine aminotransferase activity von ZEUZEM, S., ALBERTI, A., ROSENBERG, W., MARCELLIN, P., DIAGO, M., NEGRO, F., PRATI, D., PUOTI, C., ROBERTS, S. K., SHIFFMAN, M. L.

Volltext

Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy von Sanyal, AJ, Freedman, AM, Luketic, VA, Purdum, PP, Shiffman, ML, Tisnado, J, Cole, PE

Volltext

A prospective, randomized‐controlled pilot study of ursodeoxycholic acid combined with mycophenolate mofetil in the treatment of primary sclerosing cholangitis von Sterling, R. K., Salvatori, J. J., Luketic, V. A., Sanyal, A. J., Fulcher, A. S., Stravitz, R. T., Contos, M. J., Mills, A. S., Shiffman, M. L.

Volltext

The spectrum of hepatic functional impairment in compensated chronic hepatitis C : results from the Hepatitis C Anti-viral Long-term Treatment against Cirrhosis Trial von EVERSON, G. T, SHIFFMAN, M. L, MORGAN, T. R, HOEFS, J. C, STERLING, R. K, WAGNER, D. A, KULIG, C. C, CURTO, T. M, WRIGHT, E. C

Volltext

Portal‐systemic shunting in patients with fibrosis or cirrhosis due to chronic hepatitis C: the minimal model for measuring cholate clearances and shunt von EVERSON, G. T., MARTUCCI, M. A., SHIFFMAN, M. L., STERLING, R. K., MORGAN, T. R., HOEFS, J. C.

Volltext

Long-term clearance of hepatitis C virus following interferon [alpha]-2b or peginterferon [alpha]-2b, alone or in combination with ribavirin von Manns, M. P, Pockros, P. J, Norkrans, G, Smith, C. I, Morgan, T. R, Häussinger, D, Shiffman, M. L, Hadziyannis, S. J, Schmidt, W. N, Jacobson, I. M, Bárcena, R, Schiff, E. R, Shaikh, O. S, Bacon, B, Marcellin, P, Deng, W, Esteban-Mur, R, Poynard, T, Pedicone, L. D, Brass, C. A, Albrecht, J. K, Gordon, S. C

Volltext

Relationship between biochemical, virological, and histological response during interferon treatment of chronic hepatitis C von Shiffman, M L, Hofmann, C M, Thompson, E B, Ferreira‐Gonzalez, A, Contos, M J, Koshy, A, Luketic, V A, Sanyal, A J, Mills, A S, Garrett, C T

Volltext

Peginterferon alfa‐2a/ribavirin in hepatitis C virus patients nontolerant or nonresponsive to peginterferon alfa‐2b/ribavirin von RUSTGI, V. K., ESPOSITO, S., HAMZEH, F. M., SHIFFMAN, M. L.

Volltext